CALR and cardiac hypertrophy: We previously demonstrated experimentally in mice that overexpression of calreticulin in CardiacCRT+ cardiomyocytes led to development of severe cardiac pathology characterized by cardiac hypertrophy, cardiomyopathy, cardiac fibrosis and heart failure [16, 17].